-transparent.png){kind=logo}
Bone scans or skeletal surveys were obtained in 104 patients with ovarian carcinoma. No metastases were identified at staging in the 43 patients with Stage I or II disease. Four patients in the entire series had osseous metastases. Three of the 40 patients with Stage III epithelial ovarian carcinoma had osseous metastases at the time of staging. All of these were Grade III lesions. One Stage I, Grade III patient demonstrated osseous metastases two years after initial diagnosis. None of the four patients with osseous metastases had an elevated alkaline phosphatase; three of the four had bone pain. Based on these results, it is suggested that radiographic bone survey and radionuclide bone scans are not indicated as screening procedures in asymptomatic patients with ovarian carcinoma.
F A Mettler, and
J H Christie, and
N E Crow, and
J F Garcia, and
J D Wicks, and
S A Bartow
November 1996,
Urology,
F A Mettler, and
J H Christie, and
N E Crow, and
J F Garcia, and
J D Wicks, and
S A Bartow
September 1991,
Urology,
F A Mettler, and
J H Christie, and
N E Crow, and
J F Garcia, and
J D Wicks, and
S A Bartow
October 1996,
Pediatric radiology,
F A Mettler, and
J H Christie, and
N E Crow, and
J F Garcia, and
J D Wicks, and
S A Bartow
January 1997,
Digestive diseases and sciences,
F A Mettler, and
J H Christie, and
N E Crow, and
J F Garcia, and
J D Wicks, and
S A Bartow
April 1978,
Mayo Clinic proceedings,
F A Mettler, and
J H Christie, and
N E Crow, and
J F Garcia, and
J D Wicks, and
S A Bartow
January 2015,
International journal of clinical and experimental medicine,
F A Mettler, and
J H Christie, and
N E Crow, and
J F Garcia, and
J D Wicks, and
S A Bartow
February 1995,
Gut,
F A Mettler, and
J H Christie, and
N E Crow, and
J F Garcia, and
J D Wicks, and
S A Bartow
January 1988,
International urology and nephrology,
F A Mettler, and
J H Christie, and
N E Crow, and
J F Garcia, and
J D Wicks, and
S A Bartow
December 1995,
European journal of cancer (Oxford, England : 1990),
F A Mettler, and
J H Christie, and
N E Crow, and
J F Garcia, and
J D Wicks, and
S A Bartow
February 1995,
International journal of oncology,
